Page last updated: 2024-10-26

dibucaine and Hansen Disease

dibucaine has been researched along with Hansen Disease in 3 studies

Dibucaine: A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
cinchocaine : A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navarrete, JI1
Lisker, R1
Pérez-Briceńo, R1
Agarwal, DP1
Goedde, HW1
Schloot, W1
Flatz, G1
Rohde, R1
Thomas, M1
Job, CK1

Other Studies

3 other studies available for dibucaine and Hansen Disease

ArticleYear
Serum atypical pseudocholinesterase and leprosy.
    International journal of dermatology, 1979, Volume: 18, Issue:10

    Topics: Butyrylcholinesterase; Cholinesterases; Dibucaine; Female; Humans; Leprosy; Male; Mexico; Middle Age

1979
A note on atypical serum cholinesterase and genetic factors in leprosy.
    Human heredity, 1973, Volume: 23, Issue:4

    Topics: Cholinesterase Inhibitors; Cholinesterases; Dapsone; Dibucaine; Ethiopia; Genetic Variation; Humans;

1973
Serum atypical pseudocholinesterase and genetic factors in leprosy.
    British medical journal, 1972, Aug-12, Volume: 3, Issue:5823

    Topics: Cholinesterase Inhibitors; Cholinesterases; Dibucaine; Humans; Leprosy

1972